s-adenosylmethionine has been researched along with Breast Neoplasms in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (17.39) | 29.6817 |
2010's | 12 (52.17) | 24.3611 |
2020's | 7 (30.43) | 2.80 |
Authors | Studies |
---|---|
Chow, HH; Hu, C; Keun, HC; Lang, JE; Miller, JA; Pappan, K; Siskos, AP; Thompson, PA; Want, EJ; Wulff, J | 1 |
Boeing, H; Floegel, A; Johnson, T; Kaaks, R; Kühn, T; Otto, W; Rolle-Kampczyk, U; Sookthai, D; von Bergen, M | 1 |
Chughtai, K; Glunde, K; Greenwood, TR; Heeren, RM; Jiang, L | 1 |
Bah, S; Cisse, K; Coulibaly, B; Dehbi, H; Diakite, B; Diarra, F; Dolo, G; Holl, JL; Hou, L; Joyce, B; Kamate, B; Kassogue, O; Kassogue, Y; Keita, ML; Kim, K; Ly, M; Maiga, M; Murphy, R; Nadifi, S; Sidibe, FM; Sissoko, AS; Sissoko, SB; Teguete, I; Traore, CB; Traore, D; Wang, J | 1 |
Chen, K; Gong, J; Liu, F; Peng, Y; Qiao, Y; Si, C; Song, F; Wang, P; Wang, X; Zhou, H | 1 |
Arakelian, A; Cheishvili, D; Mahmood, N; Rabbani, SA; Szyf, M | 1 |
Cabezas-Herrera, J; González-Guerrero, R; Montenegro, MF; Piñero-Madrona, A; Rodríguez-López, JN; Sánchez-Del-Campo, L | 1 |
Audet-Walsh, E; Dufour, CR; Giguère, V; McGuirk, S; St-Pierre, J; Vernier, M; Wan, L | 1 |
Borzacchiello, L; Cacciapuoti, G; Caraglia, M; Coppola, A; Ilisso, CP; Mosca, L; Pagano, M; Porcelli, M; Vitiello, F | 1 |
Ali, ES; Asara, JM; Ben-Sahra, I; Gao, P; Helmin, KA; O'Hara, BP; Sahu, U; Singer, BD; Villa, E | 1 |
Cacciapuoti, G; Caraglia, M; Cave, DD; Desiderio, V; Ilisso, CP; Mele, L; Mosca, L; Porcelli, M | 1 |
Blanco-González, E; Cuyàs, E; Fernández-Arroyo, S; García, RÁ; Joven, J; Menendez, JA; Montes-Bayón, M; Neuzil, J; Stursa, J; Verdura, S; Viollet, B; Werner, L | 1 |
Chik, F; Machnes, Z; Szyf, M | 1 |
Cacciapuoti, G; Caraglia, M; Castellano, M; Dicitore, A; Ilisso, CP; Lombardi, A; Porcelli, M; Vitale, G; Zappavigna, S | 1 |
Choi, MC; Im, JH; Kang, KW; Kim, SK; Kim, YM; Lee, KY; Lim, SC; Phuong, NT; Yang, JW; Yoon, JH | 1 |
Kovalchuk, O; Luzhna, L | 1 |
Ahn, SG; Kang, KW; Kim, HS; Kim, SK; Kim, TH; Lee, KY; Lim, SC; Phuong, NT; Yoon, JH | 1 |
Kang, KW; Kim, SK; Kwak, HC; Lee, JY; Oh, SJ; Phuong, NT; Ryu, CS | 1 |
Booher, K; Borrego, SL; Kaiser, P; Lin, DW | 1 |
Farias-Eisner, R; Pakneshan, P; Rabbani, SA; Szyf, M | 1 |
Clarke, S; Frankel, A; Gutmann, DH; Herschman, HR; Jiang, W; Miranda, TB; Newsham, IF; Robb, VA; Roemer, ME; Singh, V | 1 |
Bullinger, D; Fehm, T; Gleiter, CH; Kammerer, B; Laufer, S; Neubauer, H | 1 |
Goodman, JE; Helzlsouer, KJ; Lavigne, JA; Selhub, J; Strickland, PT; Wu, K; Yager, JD | 1 |
1 review(s) available for s-adenosylmethionine and Breast Neoplasms
Article | Year |
---|---|
Therapeutic Potential of the Natural Compound S-Adenosylmethionine as a Chemoprotective Synergistic Agent in Breast, and Head and Neck Cancer Treatment: Current Status of Research.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Male; Neoplasm Metastasis; S-Adenosylmethionine; Squamous Cell Carcinoma of Head and Neck | 2020 |
22 other study(ies) available for s-adenosylmethionine and Breast Neoplasms
Article | Year |
---|---|
Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.
Topics: Amino Acids; Anticarcinogenic Agents; Antineoplastic Agents; Bile Acids and Salts; Breast Neoplasms; Carnitine; Cell Cycle; Collagen; Cyclin D1; Cyclohexenes; Female; Gas Chromatography-Mass Spectrometry; Glucose; Humans; Limonene; Metabolome; Metabolomics; Plasma; Terpenes | 2015 |
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carnitine; Cohort Studies; Colorectal Neoplasms; Female; Humans; Lipid Metabolism; Lipids; Lysophosphatidylcholines; Male; Middle Aged; Neoplasms; Prospective Studies; Prostatic Neoplasms | 2016 |
Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models.
Topics: Animals; Breast Neoplasms; Carnitine; Cell Line, Tumor; Cell Transformation, Neoplastic; Humans; Mass Spectrometry; Mice; Molecular Imaging; Phosphatidylcholines; Sphingomyelins | 2013 |
Lack of Association of
Topics: Breast Neoplasms; Female; Homocysteine; Humans; Mali; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); S-Adenosylmethionine | 2023 |
Plasma One-Carbon Metabolism-Related Micronutrients and the Risk of Breast Cancer: Involvement of DNA Methylation.
Topics: Breast Neoplasms; Carbon; Case-Control Studies; Choline; Cysteine; DNA Methylation; Female; Folic Acid; Humans; Methionine; Micronutrients; Racemethionine; S-Adenosylmethionine; Trace Elements | 2023 |
S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Reproducibility of Results; S-Adenosylmethionine; Transcription, Genetic; Transcriptome; Xenograft Model Antitumor Assays | 2020 |
PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation.
Topics: Animals; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cytoplasm; DNA Repair; Epigenesis, Genetic; Female; Humans; MCF-7 Cells; Mice; Protein-Arginine N-Methyltransferases; Radiation Tolerance; Radiation, Ionizing; Repressor Proteins; S-Adenosylmethionine; Xenograft Model Antitumor Assays | 2020 |
Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Epigenesis, Genetic; ERRalpha Estrogen-Related Receptor; Female; Gene Expression Regulation, Neoplastic; Humans; Interferon Regulatory Factors; Mice; Promoter Regions, Genetic; Protein Stability; Receptors, Estrogen; S-Adenosylmethionine; Signal Transduction; Transcription, Genetic; Xenograft Model Antitumor Assays | 2020 |
mTORC1 stimulates cell growth through SAM synthesis and m
Topics: Adenosine; Animals; Base Sequence; Breast Neoplasms; Cell Cycle Proteins; Cell Proliferation; Female; HEK293 Cells; HeLa Cells; Humans; Mechanistic Target of Rapamycin Complex 1; Methionine Adenosyltransferase; Methylation; Mice, Nude; Protein Biosynthesis; Proto-Oncogene Proteins c-myc; RNA Splicing Factors; RNA, Messenger; S-Adenosylmethionine; Signal Transduction; Transcription, Genetic | 2021 |
S-Adenosylmethionine-mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Breast Neoplasms; Cell Proliferation; Chloroquine; Dose-Response Relationship, Drug; Drug Synergism; Female; G2 Phase Cell Cycle Checkpoints; Humans; MCF-7 Cells; Microtubule-Associated Proteins; Proto-Oncogene Proteins c-akt; S-Adenosylmethionine; Signal Transduction; Time Factors | 2018 |
Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism.
Topics: AMP-Activated Protein Kinases; Animals; Biomarkers, Tumor; Breast Neoplasms; Carbon; Colonic Neoplasms; DNA Methylation; Electron Transport Complex I; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Hypoglycemic Agents; Metformin; Mice; Mitochondria; S-Adenosylhomocysteine; S-Adenosylmethionine; Tumor Cells, Cultured | 2018 |
Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2'-deoxycytidine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Breast Neoplasms; Cell Line, Tumor; Decitabine; DNA Methylation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Matrix Metalloproteinase 2; MCF-7 Cells; S-Adenosylmethionine; Urokinase-Type Plasminogen Activator | 2014 |
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines.
Topics: Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Synergism; Humans; S-Adenosylmethionine; Tissue Banks | 2015 |
Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; DNA Methylation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Methionine Adenosyltransferase; MicroRNAs; NF-E2-Related Factor 2; NF-kappa B; Promoter Regions, Genetic; PTEN Phosphohydrolase; S-Adenosylmethionine; Signal Transduction; Tamoxifen; Transcription Factor AP-1; Tumor Cells, Cultured | 2016 |
Modulation of DNA methylation levels sensitizes doxorubicin-resistant breast adenocarcinoma cells to radiation-induced apoptosis.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; DNA Methylation; Doxorubicin; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Humans; Radiation Tolerance; S-Adenosylmethionine | 2010 |
Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Azacitidine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Resistance, Neoplasm; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; PTEN Phosphohydrolase; S-Adenosylmethionine; Tamoxifen; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cystathionine gamma-Lyase; Cysteine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Glutamate-Cysteine Ligase; Glutathione; Humans; Membrane Transport Modulators; Methionine; Methylation; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; S-Adenosylhomocysteine; S-Adenosylmethionine; Tamoxifen; Taurine; Up-Regulation | 2013 |
Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells.
Topics: Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromatin; Cyclin-Dependent Kinase 2; Down-Regulation; Female; G1 Phase Cell Cycle Checkpoints; Homocysteine; Humans; MCF-7 Cells; Mechanistic Target of Rapamycin Complex 1; Methionine; Multiprotein Complexes; Nuclear Proteins; Phosphorylation; Proteins; Proto-Oncogene Proteins c-akt; S-Adenosylmethionine; TOR Serine-Threonine Kinases | 2012 |
Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis.
Topics: Animals; Base Sequence; Breast Neoplasms; Cell Division; Cell Line, Tumor; DNA Methylation; DNA, Neoplasm; Female; Gene Expression; Gene Silencing; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Oligodeoxyribonucleotides, Antisense; Promoter Regions, Genetic; S-Adenosylmethionine; Transplantation, Heterologous; Urokinase-Type Plasminogen Activator | 2004 |
DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cloning, Molecular; Humans; Lung Neoplasms; Membrane Proteins; Methylation; Microfilament Proteins; Protein-Arginine N-Methyltransferases; Recombinant Proteins; S-Adenosylmethionine; Saccharomyces cerevisiae; Tumor Suppressor Proteins | 2004 |
Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling.
Topics: Adenosine; Aminoimidazole Carboxamide; Biomarkers, Tumor; Breast Neoplasms; Cell Line; Cell Line, Tumor; Epithelial Cells; Female; Guanosine; Humans; Imidazoles; Ions; Mammary Glands, Human; Metabolic Networks and Pathways; Ribonucleosides; Ribose; S-Adenosylmethionine; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Uridine | 2007 |
COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk.
Topics: Breast Neoplasms; Case-Control Studies; Catechol O-Methyltransferase; Cysteine; Estrogens, Catechol; Female; Folic Acid; Genotype; Homocysteine; Humans; Methylation; Micronutrients; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyridoxal Phosphate; Risk Factors; S-Adenosylmethionine; Vitamin B 12 | 2001 |